COVID-19 and World Trade
Geneva: The government of Bolivia has formally notified the WTO of the country’s need to import COVID-19 vaccines, taking another step towards using flexibilities in WTO intellectual property rules as part of its pandemic response.
Bolivia notified the WTO it needed to import 15 million doses of a vaccine under the legal system introduced in a 2017 amendment to the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). That amendment, which created Article 31bis of the TRIPS Agreement, provides an additional legal pathway for import-reliant countries to access affordable medicines, vaccines and other pharmaceutical products.
Bolivia’s submission follows through on its February notification signalling that it intended to exercise the flexibilities under the amendment. Its notification opens up the possibility of importing the needed vaccines from any one of around 50 WTO members that have put in place domestic laws providing for the production and export of medicines made under compulsory licence through this system.
“This is an example of a WTO member seeking to make use of available tools under the TRIPS Agreement to respond to the COVID-19 pandemic, even as members seek to expand the range of options through the TRIPS waiver proposal,” said Antony Taubman, Director of the WTO’s Intellectual Property Division. “This step provides one practical component of what could be a wider process of countries signalling urgent and unmet needs and encouraging a combined, coordinated response by international partners.”
Also read:
- US supports TRIPS waiver to combat COVID-19 pandemic
- TRIPS Council to continue to discuss temporary Intellectual Property waiver in view of COVID-19
The WTO Secretariat stated today that it has been encouraged by members in the TRIPS Council to provide any necessary technical assistance to facilitate use of the system to import pharmaceutical products manufactured under compulsory licence.
Meanwhile, during her visit to Rome (Italy holds the current presidency of the G20 group of large economies ), the WTO Director-General Ngozi Okonjo-Iweala yesterday said that with respect to COVID-19 she hoped ministers could agree on a package of measures to reinforce global supply chains for medical products by streamlining customs procedures and cutting back on the number of export restrictions on vaccines, therapeutics and diagnostics. These restrictions have hindered efforts at ramping up vaccine production particularly in the developing world, she said.
DG Okonjo-Iweala explained that there was untapped production capacity in developing countries that needs to be employed. They also discussed the ongoing debate in Geneva on the merits of an Indian-South African proposal for temporarily waiving the WTO’s Trade Related Intellectual Property Rights Agreement for medical products — including vaccines — that can be used to combat COVID-19. The Director-General said the fact that the EU is willing to come to the table will give impetus to the negotiations.
– global bihari bureau
